TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · major macro event coming up
IRD

Opus Genetics, Inc.

Healthcare · Biotechnology

4.60$ +1.6% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet IRD
Line item 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
98.8% 99.9% 100.0% 100.0% 100.0% 99.3% 99.6%
86.2% 92.7% 94.1% 87.0% 93.6% 82.3% 89.7%
86.2% 92.7% 94.9% 87.1% 93.6% 82.3% 89.7%
7.0% – 0.0% 9.9% 4.3% 15.7% 6.3%
523.8% 176.2% 14.8% 5.6% 7.5% 81.8% 69.5%
523.8% 18.0% 14.8% 5.6% 7.5% 30.6% 15.5%
317.7% – 2.1% – – – –
19.2% 6.9% 6.1% 2.2% 4.0% 8.5% 6.6%
– – – – – – 2.2%
-423.8% -76.2% 85.2% 94.4% 92.5% 18.2% 30.5%
-451.5% -184.8% -342.7% -145.9% -151.0% -377.1% -375.4%
397.5% 26.4% 57.0% 42.0% 40.0% 72.5% 1,238.4%

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?